Jan 22 (Reuters) - Moderna does not plan to invest in new late-stage vaccine trials because of growing opposition to immunizations from U.S. officials, CEO Stephane Bancel said in an interview ...
"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street ...
ORLANDO, FLORIDA / ACCESS Newswire / January 16, 2026 / RedChip Companies will air interviews with Alliance Entertainment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results